Demand For Thoracic Drainage Devices Is Expected To Rise At A CAGR Of 5.2% By 2032

According to Fact.MR, a provider of market research and competitor information, sales of thoracic drainage devices are expected to increase globally at a CAGR of 4.6% and approach US$ 1 billion by 2032.

The market is estimated to expand gradually throughout the anticipated time period as a result of the swift surge in technological developments in medical devices.

Download Sample Copy of This Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=7804?pk

The removal of air, fluid, and particulates from the pleural cavity or chest mediastinum is the main goal of thoracic drainage devices.

The global increase in cardiovascular diseases, hypertension, diabetes, and obesity is the main factor driving demand for thoracic drainage devices.

They are used in a variety of medical specialties, including thoracic surgery, infectious disease, pulmonology, emergency medicine, general critical care, cardiology, cancer, and pain management. They are frequently made of transparent plastics such soft silicone or PVC.

Also, it is anticipated that rising demand for early disease diagnosis and treatment will accelerate market sales growth. Furthermore, respective government's favourable reimbursement policies and rising incidence of spontaneous pneumothorax are expected to boost demand for thoracic drainage devices.

It is also projected that growing healthcare costs connected with minimally invasive procedures and their rising popularity will support the expansion of the device market.

As more individuals learn about the implications of MPE and the value of early diagnosis, there will be an increase in the demand for chest wall drainage devices.

Heart diseases are now more common than ever, with 26 million cases reported in the past year alone, and millions more cases that are still unreported.

The ageing of the population, rising cardiovascular risk factors, sedentary lifestyles, etc. are all contributing factors in this.

• Heart failure is a potentially fatal illness that lowers the quality of life and raises medical expenses. Approximately 550,000 new cases of congestive heart failure (CHF) are identified in the U.S. each year, according to the American Heart Association (AHA).
• Furthermore, 750,000 people in Canada have been diagnosed with heart failure, and that number is rising every year, according to a Heart and Stroke Foundation of Canada report from February 2022.

Every year, the number of surgical procedures, particularly cardiothoracic surgeries, is rising. Thus, this rise in surgical procedures has contributed to an increase in thoracic drainage device sales.

Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=7804?pk

Key Takeaways from Market Study

• The global market for thoracic drainage devices is currently valued at US$ 688 million.
• The market is projected to reach US$ 1.07 billion by 2032.
• China's thoracic drainage devices market is predicted to rise at a CAGR of 4.3% from 2022 to 2032.
• Demand for thoracic drainage devices utilized in thoracic surgeries and pulmonology is expected to rise at a CAGR of 5.2% from 2022 to 2032.

Segments of Thoracic Drainage Devices Industry Research

• By Product :
o Pleural Drainage Catheters
o Secured Needles
o Thoracic Drainage Kits
o Thoracic Drainage Systems
• By Application :
o Thoracic Surgeries & Pulmonology
o Cardiac Surgeries
o General Intensive Care & Emergency Medicine
o Infectious Diseases
o Others
• By End User :
o Hospitals
o Ambulatory Surgical Centers
o Specialty Clinics
o Others
• By Region :
o North America
o Latin America
o Europe
o East Asia
o South Asia & Oceania
o MEA

Get Free Access of Complete Report - https://www.factmr.com/checkout/7804

Winning Strategy

Prominent manufacturers of thoracic drainage devices are Merit Medical Systems, Medela LLC, Smiths Medical, ATMOS MedizinTechnik GmbH & Co., KG., Becton, Dickinson Company, Cook Group, Inc., Maquet Holding B.V. & Co. KG, and Medela, Inc.
The leading cause for the development of thoracic drainage devices is the rising cases of chronic diseases. Leading manufacturers of thoracic drainage devices are adopting cutting-edge technologies and product line optimization strategies based on end user usability.

• To lower the chance of Covid-19 spreading in its respiratory wards, Blackpool Victoria Hospital announced in October 2020 that it had partnered with Medela Healthcare and will utilise Medela's portable chest drainage equipment Thopaz+.
• To enhance the tracking of medical supplies, pharmaceuticals, first aid kits, and personal protective equipment (PPE) in transit to pharmacies, hospitals, and other care facilities around the world, FourKites and Cardinal Health, Inc. established a global partnership in March 2021. For the 29,000 dispensaries and almost 90% of American hospitals that depend on Cardinal Health for essential supplies, FourKites' excellent analytics and tracking capabilities were anticipated to help Cardinal Health improve supply chain processes and enable a quick, dependable, and frictionless experience.

US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.